Growth factor-induced stress fiber formation involves signal transduction through Rac and Rho proteins and production of leukotrienes from arachidonic acid metabolism. In exploring the relationship between these pathways, we found that Rac is essential for EGFinduced arachidonic acid production and subsequent generation of leukotrienes and that Rac V12, a constitutively activated mutant of Rac, generates leukotrienes in a growth factor-independent manner. Leukotrienes generated by EGF or Rac V12 are necessary and sufficient for stress fiber formation. Furthermore, leukotriene-dependent stress fiber formation requires Rho proteins. We have therefore identified elements of a pathway from growth factor receptors that includes Rac, arachidonic acid production, arachidonic acid metabolism to leukotrienes, and leukotriene-dependent Rho activation. This appears to be the major pathway by which Rac influences Rho-dependent cytoskeleton rearrangements.
Introduction
The action of growth factors coupled to receptor proteintyrosine kinases often includes the induction of cellular migration, which is important in, for instance, wound healing, metastasis of tumors, and pattern formation (e.g., Grotendorst, 1984) . These growth factor-induced migratory events are brought about by a reorganization of the actin cytoskeleton (e.g., Schlessinger and Geiger, 1981) and are accompanied by the phosphorylation and reorganization of other cytoskeletal components (e.g., Bretcher, 1989) . The signal transduction pathways leading from receptor activation to actin remodeling are still unclear, but involve members of the family of Ras-related small GTPases. In particular, the Rac and Rho proteins have been implicated in growth factor-induced cytoskeletal reorganization in Swiss 3T3 cells . In these cells, epidermal growth factor (EGF) and platelet-derived growth factor first evoke rapid actin polymerization at the plasma membrane to produce membrane ruffles and lamellipodia, followed by the appearance of stress fibers. Microinjection of dominant negative Rac proteins (Rac N 17) prior to growth factor addition abolishes these effects, while injection of constitutively active Rac (Rac V12) is sufficient to induce plasma membrane-localized actin polymerization and subsequent stress fiber formation in the absence of exogeneous factors.
In addition, stress fiber assembly, but not the membrane ruffling, induced either by growth factors or by microinjection of Rac V12, is abrogated by C3 transferase. This exoenzyme derived from Clostridium botulinum inactivates Rho proteins by ADP-ribosylation of Asp-41 (Aktories et al., 1989; Sekine et al., 1989) . Furthermore, microinjection of quiescent Swiss 3T3 fibroblasts with Rho V14 is sufficient in itself to produce stress fiber formation . From these data, it can be inferred, at least for Swiss 3T3 fibroblasts, that growth factors first activate Rac, leading to actin polymerization at the plasma membrane, and that Rac in turn activates Rho, leading to the formation of stress fibers.
Fetal calf serum (FCS), lysophosphatidic acid (LPA), and bombesin also lead to the formation of stress fibers in a Rho-dependent manner. However, in contrast with growth factor-induced stress fiber assembly, these stimuli act independently of Rac. Therefore, at least two different signal transduction pathways exist, leading to the stimulation of Rho and subsequent stress fiber formation, one Rac dependent and one Rac independent.
Apart from Rac and Rho, metabolites of arachidonic acid are also implicated in growth factor-induced actin remodeling (Peppelenbosch et al., 1993) . In A431 cells, EGF provokes a cortical actin polymerization accompanied by a breakdown of cytoplasmic actin filaments. Inhibition of cyclooxygenase (responsible for the conversion of arachidonic acid to prostaglandins) abolishes the breakdown of cytoplasmic actin filaments, whereas inhibition of 5-1ipoxy-genase (a key enzyme in the biosynthesis of leukotrienes from arachidonic acid) prevents cortical actin polymerization. Finally, cortical actin polymerization can be induced by the application of leukotrienes in the absence of added growth factors. EGF-induced cytoskeletal reorganization involves, therefore, the small GTPases Rac and Rho, as well as arachidonic acid metabolites.
To explore the possible relationship between the action of Rac and Rho and arachidonic acid metabolism, we have examined EGF-induced actin remodeling in Swiss 3T3 cells, where the role of Rac and Rho is best understood. The results reveal that Rac-induced stress fiber formation is abrogated by inhibitors of leukotriene synthesis, whereas application of leukotrienes is sufficient to activate Rho and produce stress fibers. Importantly, EGF-stimulated arachidonic acid release and leukotriene production are blocked by expressing dominant negative Rac proteins, while in cells expressing a constitutively active Rac protein the level of leukotrienes is elevated. Our results show, therefore, that induction of arachidonic acid release and leukotriene production is one of the major biochemical pathways by which Rac can influence cytoskeletal architecture.
Results

EGF-Induced, but Not LPA-Induced, Stress Fiber Formation Requires Lipoxygenase Activity
To study the possible interactions between arachidonic acid metabolism and the small GTPases Rac and Rho in controlling EGF-induced actin polymerization, we have used Swiss 3T3 fibroblasts, where the action of Rac and Rho is well described . Using rhodamine-labeled phalloidin, we observed that serum-starved Swiss 3T3 fibroblasts contain little polymerized actin (Figure la ). Upon addition of EGF (20 ng/ ml) to these cells, dramatic changes in actin structure take place. Actin polymerization first occurs at the plasma membrane (membrane ruffles and lamellipodia), and this is followed, somewhat later ( -1 0 min) by the formation of stress fibers (Figure lb) . Inhibition of 5-1ipoxygenase, by a 10 min preincubation with nordihydroguaretic acid (NDGA; 3 p.M), did not influence actin polymerization at the plasma membrane, but abolished the EGF-induced formation of stress fibers (Figure lc) . Also, the stress fiber formation induced by platelet-derived growth factor and insulin was sensitive to NDGA (data not shown). Similar results were obtained using a 10 min preincubation with 200 nM MK-886 (which inhibits 5-1ipoxygenase-activating protein; Gillard et al., 1989; Dixon et al., 1990; ; data not shown). The results show that lipoxy- Figure 2 . Inhibition of Leukotriena E4-1nduced Stress Fiber Formation by C3 Transferase Swiss 3T3 cells were injected with 100 p,g/ml C3 transferase. Fluorescain complexon was coinjected to facilitate recognition of injected cells. Subsequently, cells were treated for 10 rain with leukotriane E4, fixed, stained, and investigated with confocal laser scannings microscopy. To the left, the fluorescein image is presented and clearly shows the outlines of the C3 transferase-injected cell. To the right, the rhodamine picture reveals the nature of the actin cytoskeleton of the injected and uninjected cells. Mock-injected cells did not show alterations in their cytoskeleton. genase is required for growth factor-induced formation of stress fibers.
Independent support for this hypothesis was obtained by adding different leukotrienes directly to serum-starved cells. The addition of leukotriene E4 (0.8 p,M) produces a rapid assembly of parallel stress fibers (maximal effect reached in 5 rain; Figure ld) , which persist for at least 30 min. Leukotrienes did not induce any cortical actin polymerization or ruffling. Similar results were obtained with leukotriene D4 (0.7 p,M) and with leukotriene C4 (0.5 IIM) (data not shown). Inhibition of cyclooxygenase with indomethacin (20 pM; 10 min preincubation) had no effect on the EGF-induced actin reorganization in these cells (data not shown). From these results we conclude that leukotriene synthesis is required for EGF-induced stress fiber assembly, but not for EGF-induced membrane ruffling.
To obtain further insight into the role of leukotriene synthesis in stress fiber formation, we studied the effects of NDGA and MK-886 on the induction of stress fibers by LPA (2.5 p.M). This agonist induces rapid stress fiber formation in Swiss 3T3 fibroblasts, with a maximal effect after 10 min (Figure 1 e), without any accompanying cortical actin polymerization. Preincubation of the cells with either NDGA (10 p.M; 10 min preincubation; Figure lf ) or MK-886 (200 nM; 10 min preincubation; data not shown) did not influence the assembly of new stress fibers provoked by LPA. Similar results were obtained for two other stimuli, i.e., FCS (10%) and bombesin (10 nM). Therefore, FCS, LPA, and bombesin do not require lipoxygenase activity in the signal trensduction pathway leading to stress fiber formation.
EGF-induced plasma membrane actin polymerization and stress fiber formation are both mediated by Rac in Swiss 3T3 cells . However, as shown above, only the latter is sensitive to lipoxygenase inhibi- tion. Since both EGF-induced (Rac-dependent) stress fiber formation and LPA-induced (Rac-independent) stress fiber formation are mediated by Rho , but only EGF-induced stress fiber formation requires lipoxygenase activity, we hypothesized that leukotrienes mediate signaling from Rac to Rho.
Leukotriene-lnduced Stress Fiber Assembly Is Mediated by Rho
To obtain further insight into the mechanism by which leukotrienes induce stress fiber formation in Swiss 3T3 fibroblasts, we have investigated whether leukotriene-induced stress fiber formation is dependent on Rho, Cells were injected with 100 ~tg/ml C3 transferase, which inhibits Rho, but not Rac or CDC42 function . To identify microinjected cells, we coinjected fluorescein complexon (1 mg/ml) with C3 transferase. Subsequently, the cells were treated with leukotriene E4 for 10 min. We observed that the leukotrienedependent induction of stress fibers was completely inhibited by the C3 transferase (Figure 2 ), demonstrating that leukotriene-induced stress fiber formation requires functional Rho protein.
EGF-Induced Leukotriene Synthesis Is Dependent on Functional Rac
To address whether Rac mediates growth factor-induced lipoxygenase metabolism, we have introduced a dominant negative mutant of Rac, Rac N17 , into cells using a vaccinia virus (VV) expression system previously shown to be a successful way of assessing the role of Ras in signal transduction (de Vries-Smits et al., 1992; Burgering et al., 1993; Medema et al., 1993) . Recombinant VV expressing Rac N17 (W-Rac N17) was used to infect both Swiss 3T3 and A14 fibroblasts. By 16 hr postinfection, the cells showed a clear expression of the transgene ( Figure 3A ), in contrast with the cells infected with wild-type VV. As shown in Figure 3B for Swiss 3T3 cells and Figure 3C for A14 cells, infection with WRac N17 inhibited EGF-dependent leukotriene production while wild-type VV infection had no effect. To exclude the possibility that Rac N17 acts as a dominant negative Ras protein, we also analyzed the effect of VV-Rac N17 on the phosphorylation of extracellular signal-regulated kinase 2 (ERK2). In particular, after insulin stimulation of A14 cells, this process is completely dependent on Ras (de Vries-Smits et al., 1992; Burgering et al., 1993) . Whereas infection with VV-Ras N17 abolished the insulin-induced activation of ERK2, expression of Rac N17 had no effect on either insulin-induced or EGF-induced activation of ERK2 ( Figure 3D ). We concluded that EGF-induced leukotriene production requires functional Rac protein.
Leukotriene Synthesis Is Enhanced by Rac V12 Expression, but Not by Rho V14 Expression
If Rac mediates EGF-induced synthesis of leukotrienes, constitutive activation of Rac would be expected to induce leukotriene synthesis in the absence of growth factors. To test this, we introduced a mutant Rac V12 protein into Rat-1 fibroblasts by DNA transfection (see Experimental Procedures), since Swiss 3T3 are very difficult to transfect. Two resulting Rac V12-expressing cell lines show constitutive ruffling and also show a moderate increase in stress fibers that is sensitive to treatment with NDGA ( Figures  4c and 4d ). In accordance with this, the two representative cell lines had leukotriene levels that were substantially higher than in control cells, even after EGF stimulation ( Figure 5 ). Addition of EGF did not have an additional effect on the high constitutive leukotriene synthesis in Rac V12-expressing lines. In contrast, in cells expressing Rac N17, EGF-induced ruffling was inhibited (Quiet al., submitted), but leukotriene-induced stress fiber formation was not affected by expressing Rac N 17 (Figures 4a and 4b) . A representative Rac N17 cell line did not show elevated leukotriene synthesis, nor did it show an increase in leukotriene synthesis upon EGF treatment ( Figure 5 ). In all these cells, EGF-induced activation of ERK2 was not affected by the mutant Rac proteins, indicating the presence of functional EGF receptors (data not shown). These results suggest that Rac is required for growth factor-induced leukotriene synthesis.
To assess the role of Rho, if any, in leukotriene synthesis, we have isolated clones of Rat-1 fibroblasts expressing activated Rho protein (Rho V14). These cell lines have, in comparison to the parental cell line, a very high number of stress fibers, which are not diminished upon treatment with NDGA, providing further evidence for the notion that Rho-induced stress fiber formation does not require arachidonic acid metabolism (Figures 4e and 4f) . Expression of Rho V14 did not affect significantly the levels of leukotriene synthesis, nor did Rho V14 affect leukotriene production after treatment with EGF ( Figure 5 ). 
Rac N17 Influences Leukotriene Synthesis by Inhibiting Arachidonic Acid Release
The rate-limiting step in the biosynthesis of leukotrienes is the release of arachidonic acid from membrane phospholipids, Arachidonic acid is subsequently metabolized via the different enzymes of the 5-1ipoxygenase pathway to produce leukotrienes. To establish whether the effect of Rac N17 on leukotriene synthesis is upstream or downstream of arachidonic acid release, we incubated wild-type VV-infected or VV-Rac N 17-infected A14 cells with snake venom phospholipase A2 (PLA2), Addition of this PLA2 provokes leukotriene synthesis in a concentration-dependent fashion ( Figure 6A ). Importantly, there was no difference between the wild-type VV-infected and VV-Rac N17-infected ceils. Furthermore, leukotriene synthesis induced by application of exogeneous arachidonic acid was not different in wild-type VV-infected and VV-Rac N17-infected cells ( Figure 6B ). We conclude that the inhibitory effect of Rac N 17 expression on EGF-induced leukotriene synthesis is upstream of arachidonic acid release. We have confirmed this by directly measuring arachidonic acid release in wild-type VV-infected, VV-Rac-infected, and VV-Rac N17-infected cells. Overexpression of wildtype Rac proteins resulted in increased arachidonic acid release in response to EGF, whereas expression of the Rac N17 protein eliminated the EGF-induced increase in arachidonic acid release ( Figure 6C ). In accordance with this, the insulin-induced increase in arachidonic acid release is also completely inhibited by Rac N17 (Figure 6D ), indicating that the involvement of Rac in arachidonic acid release is not restricted to EGF. Together these results show that functional Rac protein is essential for EGF-and insulin-induced release of arachidonic acid from biological phospholipids.
Discussion
It has previously been shown that in fibroblasts the small GTPases Rac and Rho are required sequentially for EGFinduced changes in the actin cytoskeleton . We have now examined the relationship between these two small GTPases and arachidonic acid metabolism (Peppelenbosch et al., 1993) . We first showed that leukotrienes, one of the products of arachidonic acid metabolism, are required for some, but not all, of the EGF-induced cytoskeletal rearrangements in Swiss 3"1"3 cells. In these cells, EGF induces two clear cytoskeletal alterations, i.e., a rapid induction of membrane ruffling and, later, the formation of stress fibers. Inhibitors of leukotriene synthesis, i.e., NDGA and MK-886, abolished EGF-induced stress fiber formation, but not membrane ruffling. Furthermore, addition of leukotrienes to serum-starved Swiss 3T3 cells is sufficient for the induction of stress fibers. These results are in agreement with our earlier reports that leukotriene synthesis is responsible for an increase in total actin polymerization of Rat-1 and A431 cells (Peppelenbosch et al., 1993) . Leukotriene-induced stress fiber formation is inhibited by microinjection of C3 transferase (Aktories et al., 1989; Sekine et al., 1989) , indicating that this effect is dependent on the Rho GTPase. FCS-, LPA-, and bombesin-induced stress fiber formation, which are also Rho dependent (RidIcy and Hall, 1992) , are insensitive to inhibitors of the leukotriene pathway, showing that these growth factors use a different, leukotriene-independent route to activate Rho and induce stress fiber formation. Since EGF-induced stress fiber formation is dependent on Rac, but FCS-, LPA-, and bombesin-induced stress fiber formation is independent of Rac , these results point to Rac being involved in leukotriene-mediated stress fiber formation. This was confirmed through the use of Rac N17, which completely inhibited EGF-induced leukotriene synthesis in Swiss 3T3, A14, and Rat-1 cell lines, whereas expression of wild-type Rac proteins stimulated EGFinduced arachidonic acid release ( Figure 5 ) as well as leukotriene production (data not shown). Moreover, Rat-1 cells expressing a constitutive active Rac V12 had elevated levels of leukotrienes, which were largely insensitive to EGF-treatment. Finally, N17 Rac was shown to inhibit the release of arachidonic acid from phospholipids. Together, these results show that EGF-induced arachidonic acid release and subsequent leukotriene synthesis are mediated by the Rac protein and that this signaling pathway leads to Rho-dependent stress fiber formation (Figure 7) . The details of the Rac-mediated signaling pathway from the EGF receptor to arachidonic acid release are not yet clear. It has been reported that phosphatidyl inositol-3 kinase is required upstream from Rac in the regulation of cytosketetal rearrangements (Nobes et al., 1995) . We have shown that EGF-induced leukotriene synthesis is sensitive to wortmannin, an inhibitor of phosphatidyl inositol-3 kinase (M. P. P. and J. L. B., unpublished data). In addition, a number of proteins have been identified that may act as guanine nucleotide exchange factors or effectors of Rac (reviewed by Hall, 1994; Lamarche and Hall, 1994) , but their role in Rac-mediated signaling and, more specifically, in EGF-induced leukotriene synthesis is not resolved. Also, the mechanism by which leukotrienes activate Rho remains obscure, but it may be that leukotrienes directly modulate Rho-controlling enzymes (Tsai et al., 1989) or that leukotrienes are secreted and subsequently activate specific extracellular receptors (Downey et al., 1990) .
Activation of cytosolic PLA2 (cPLA2) in response to growth factors has been well documented (e.g., Lin et al., 1992; Spaargaren et al., 1992; Domin and Rozengurt, 1993; Xu et al., 1994) . Therefore, cPLA2 must be regarded as a candidate target that could mediate Rac dependent arachidonic acid release. This 85 kDa protein is calcium dependent (Clark et al., 1991) and needs phosphorylation on Ser-505 for full activation. In vitro, this site is phosphorylated by ERK, indicating a possible link with Ras (Lin et al., 1993) , though the kinase responsible for in vivo phosphorylation has not been established. Rac is known to activate a Ser/Thr kinase, p65 P~< (Manser et al., 1994) , and we are currently trying to address whether cPLA2 is a substrate for p65 PAK. Alternatively, cPLA2 may bind directly to Rac, although in vitro such an interaction could not be demonstated (M. P. P. and A. H., unpublished data). Whether cPLA2 is the sole mediator of growth factorinduced arachidonic acid release, however, is still a matter of debate, "and other enzymes may be involved as well (Goldberg et al., 1994) .
In addition to Rac and Rho, Ras has also been implicated in arachidonic acid release and cytoskeletal changes. Microinjection of constitutive active Ras (Ras V12) leads to cytoskeletal remodeling and to arachidonic acid release (Bar-Sagi and Feramisco, 1986; . In addition, Warner et al. (1993) reported that Ras is essential for EGF-induced arachidonic release in Rat-1 fibroblasts. This is in apparent contrast with the observation that inhibition of Ras does not affect EGFinduced actin reorganization in Swiss 3T3 cells . One possible explanation for this apparent discrepancy may be that EGF can bypass Ras in the activation of downstream events (Burgering et al., 1993) . Indeed, in Swiss 3T3 cells, neither EGF-induced activation of ERK2 nor EGF-induced leukotriene synthesis is abolished by Ras N17, whereas in A14 cells, both insulininduced activation of ERK2 and insulin-induced leukotriene synthesis is abolished by Ras N17 (Burgering et al., 1993; M. P. P. and J. L. B, unpublished data) .
In conclusion, we have identified arachidonic acid metabolism, in particular, the lipoxygenase pathway, as the downstream pathway that mediates Rac-induced activation of Rho and the subsequent formation of stress fibers. In addition, we have established a biochemical signaling pathway mediated by Rac, which will greatly facilitate the analysis of the mechanism by which this small GTPase functions. Finally, since Rac and Rho are involved in cell migration and tumor invasiveness (e.g., Habets et al., 1994) , our findings may point to an important function of arachidonic acid metabolism in these processes as well.
Experimental Procedures
Materials and Cell Culture EGF, insulin, NDGA, indomethacin, rhodamine phalloidin, and leukotrienes were obtained from Sigma.
[~H]arachidonic acid was purchased from DuPont-New England Nuclear. MK-886 was a gift of the Merck-Frosst Centre for Therapeutic Research. Fluorescein complexon was obtained from Boehringer Mannheim.
A14 cells are NIH 3T3 cells expressing the human insulin receptor (Burgering et al., 1991) . Swiss 3T3, A14, and Rat-1 fibroblasts were cultured according to routine procedures in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% FCS. For growth factor stimulation experiments, Swiss 3T3 cells were serum-starved overnight in serum-free medium; all other cell lines were starved in 0.5% FCS.
Rat-1 cells expressing mutant Rac and Rho proteins are described elsewhere (Qiu et al., 1995) . In brief, a piasmid expressing a tetracyclincontrolled transactivator (Gossen and Bujard, 1992) was transfected into Rat-1 cells in the presence of a G418 resistance marker, and subsequently a construct expressing Rac and Rho mutants controlled by a hybrid element containing a tet operator and a cytomegalovirus minimal promotor was transfected in the presence of a puromycin resistance marker. The presence of the Rac and Rho protein was established by Western blotting. The transfected Rat-1 cells were grown in DMEM (high glucose) containing 10% FCS, 0.4 mg/ml G418, 1 p.g/ml puromycin, and 2 i~g/ml tetracyclin. Tetracyclin was withdrawn 48 hr before experimentation, which resulted in a 2-to 3-fold increase in expression of the transfected genes. The concentration of FCS was reduced to 0.5% 16 hr prior to experimentation.
Cytochemistry and Microinjection
After appropriate stimulation, cells were fixed with 2% paraformaldehyde in phosphate-buffered saline (PBS) for 15 min, washed, and permeabilized in 0.1% Triton X-100 containing PBS for 1 min, washed and blocked with 0.50/0 bovine serum albumin (BSA) in PBS for 45 min. After washing, cells were stained with rhodamine phalloidin (100 ng/ml) and mounted in Moviol. Cells were inspected by confocal laser scanning microscopy (Peppelenbosch et al., 1993) or by conventional immunofluorescence microscopy.
Microinjection of the C3 transferase (a gift of D. Diekmann) was carried out at 33°C in a buffer containing 140 mM NaCI, 5 mM KCI, 2 mM CaCI2, 1 mM MgCI2, 10 mM HEPES, and 10 mM glucose (pH 7.3) (with NaOH). Fluorescein complexon (1 mg/ml) was coinjected to facilitate recognition of injected cells. After injection, cells were stimulated in the same medium, and cytochemistry was performed as described above.
VV Infection
Dominant negative ras and rac cDNAs (Ras N17 and Rac N17) or wild-type rac were introduced into a viral growth factor-minus strain of VV by homologous recombination as described earlier (de VriesSmits et al., 1992; Medema et al., 1993) . The authenticity of the viral constructs were confirmed by sequence analysis. Wild-type and recombinant virus were grown in RK-13 cells. Swiss 3T3 and A14 cells were infected with 10-20 pfu per cell for 60 rain in serum-free medium, after which the medium was replaced with either fresh serum-free medium (Swiss 3T3 cells) or 0.5% FCS-containing medium (A14 cells). Experiments were performed 16-18 hr later.
Determination of Leukotriene Synthesis
After appropriate stimulation, leukotrienes were extracted by replacing the medium with 2 ml of ethanol. Insoluble matter was spun down at 15,000 x g for 10 rain, after which the supernatant was evaporated under a constant stream of argon. The sample was reconstituted in 100 p~l of ethanol and again evaporated, and peptidoleukotrienes (a subset of the leukotriene family) were measured using a commercially available immunoassay (Cascade Biochemicals).
Analysis of ERK2 Phosphorylation
Cells were scraped into sample buffer, and 50 pg of total protein was electrophoresed on a 10% SDS-polyacrylamide gel, blotted to nitrocellulose, and incubated with an antiserum directed against recombinant ERK2. Immune complexes were detected by horseradish peroxidase-conjugated secondary antibody, followed by enhanced chemiluminescence (Amersham).
[aH]Arachidonic Acid Release Cells were labeled with [3H]arachidonic acid (180-240 Ci/mmoI; DuPont-New England Nuclear; 200 i~Ci/106 cells) for 12 hr in 0.5°/0 FCS containing DMEM, washed extensively, and stimulated with buffer, EGF, or insulin for 1 hr in 0.2% BSA, 0.5% FCS-containing DMEM. Subsequently, the medium was collected, and released [3H]arachidonic acid was quantified by liquid scintillation counting.
